Form D · Biotechnology

Sirnaomics, Inc.

Gaithersburg, MD · CIK 0001658879

Offering snapshot reported Dec 31, 2020 · SEC filing

Reported sold
$15M
Offering amount: $15M
Investors reported
3
Form D · investor count
Minimum accepted
$1M
Reported outside-investor minimum
First sale
Oct 27, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.5M$15MDec 10, 2020: $7,000,000.00Dec 10, 2020Dec 31, 2020: $15,000,000.00Dec 31, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$7,000,000 → $15,000,000
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 31, 2020Amendment$15,000,000$8,000,000vs Dec 10, 20203SEC filing
Dec 10, 2020Initial$7,000,000No comparison2SEC filing
Dec 10, 2020Initial$89,000,000No comparison10SEC filing
Jul 15, 2019Amendment$25,000,000$0vs Jan 8, 20196SEC filing
Jul 15, 2019Amendment$23,000,000$12,000,000vs Jan 8, 20197SEC filing
Jan 8, 2019Initial$11,000,000No comparison5SEC filing
Jan 8, 2019Initial$25,000,000No comparison6SEC filing
Apr 28, 2016Amendment$10,000,000$0vs Apr 28, 20162SEC filing
Apr 28, 2016Amendment$10,000,000No comparison0SEC filing
Nov 20, 2015InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-382862

Source: Form D, filed Dec 31, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Xiaochang Dai Director
Xiaochang Dai, Ph D Director
Mike Ghias Director
Mike M Ghias, Mba Director
Mongcong (Cooper) Huang Director
George Ji Executive
Jianjun (George) Ji, Mba Director, Executive
Ping Lau Director
Ping Lau, Mba Director
Da Liu Director
Rong Lu, Mba Director
Yang (Patrick) Lu, Ph D Director, Executive
Patrick Y Lu, Ph D Director, Executive
Huang Mingcong (Cooper) Director
Michael Molyneaux Director, Executive
Michael V Molyneaux, Md, Mba Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
401 Professional Drisuite 280
Gaithersburg, MD, 20879